In this video health care analysts David Williamson and Max Macaluso discuss Pfizer's just-released third-quarter earnings. David distills the highlights and hits on all of the critical takeaways for investors, including potential blockbuster Eliquis shared with Bristol-Myers Squibb and the "bapi" Alzheimer's failure, which it shares with Elan. Watch and discover everything you need to know about Pfizer's most recent quarter.
